Proliferative pattern of exophytic and superficially invasive and noninvasive low-grade urothelial carcinomas

Human Pathology

Volumn 30, Issue 2, 1999, Pages 145-150

  Helpap, Burkhard ^a   Köllermann, Jens ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cytokeratin; Proliferation index; pT1; Stage pTa; Urinary bladder cancer

Indexed keywords

CYTOKERATIN;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INFILTRATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032978287     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90268-X     Document Type: Article

References (17)

1. Klimberg IW, Wajsman Z: Treatment for muscle invasive carcinoma of the bladder. J Urol 136:1169-1175, 1986
2. Whitmore FW Jr: Surgical management of low stage bladder cancer. Semin Oncol 6:207-216, 1979
3. Angulo JC, Lopez JI, Grignon DJ, et al: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 45:47-52, 1995
4. Holmäng S, Hedelin H, Anderström C, et al: The importance of the depth of invasion in stage T1 bladder carcinoma: A prospective cohort study. J Urol 157:800-804, 1997
5. Ro JY, Ayala AG, El-Naggar A: Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 11:668-673, 1987
6. Amin MB, Gomez JA, Young RH: Urothelial transitonal cell carcinoma with endophytic growth pattern: A discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 21:1057-1068, 1997
7. Okamura K, Miyake K, Koshikawa T, et al: Growth factions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 144:875-878, 1990
8. Sanchez-Fernandez de Sevilla MC, Morell-Quadreny L, GilSalom M, et al: Behavior of epithelial differentiation antigen (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder. Urol Int 48:14-19, 1992
9. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumors (ed 5). Wiley-Liss, New York, NY, 1997, pp 187-190
10. Helpap B, Loesevitz L, Bulatko A: Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumor. Virchows Arch 425:265-269, 1994
11. Helpap B: Grading and prognostic significance of urologic carcinomas. Urol Int 48:245-257, 1992
12. Helpap B, Giesbert A: Grading und Staging in urothelialen Harnblasencarcinomen. Dtsch Med Wochenschr 107:1274-1279, 1982
13. Sauter G, Moch H, Gasser TC, et al: Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 21:40-46, 1995
14. Moch H, Sauter G, Gudat F, et al: Ki-67 fraction, p53 alteration and numerical chromosomal aberrations (chromosomes 7 and 17) in formalin fixed bladder carcinomas. Verh Dtsch Ges Pathol 77:226-230, 1993
15. Hansen AG, Bjerregaard B, Ovesen H, et al: AgNOR counts and histological grade in stage pTa bladder tumors: Reproducibility and relation to recurrence pattern. Histopathology 20:257-262, 1992
16. Pich A, Chiusa L, Comino A, et al: Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch 424:143-148, 1994
17. Huben RP, Mounzer AM, Murphy GP: Tumor grade and stage as prognostic variables in upper tract urothelial tumor. Cancer 62:2016-2020, 1988